Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,187.00    -13.00 (-1.08%)
Bid:
1,188.00
Ask:
1,190.00
Spread: 2.00 (0.168%)
Market Cap: £825.47m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Total Voting Rights

2 Sep 2024 14:45

RNS Number : 5747C
CVS Group plc
02 September 2024
 

2 September 2024

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

 

CVS, one of the UK's leading providers of integrated veterinary services, confirms that certain employees have exercised options during August under the CVS Group 2020 SAYE Plan (2020/2024) totalling 623 ordinary shares of 0.2 pence each ("Ordinary Shares").

The sum of 623 new Ordinary Shares were issued to satisfy the balance of Ordinary Shares arising from the SAYE Exercise. Admission of the 623 new Ordinary Shares has been satisfied by the Company's block listing admitted to the London Stock Exchange on 30 December 2021. 

Following the issue of these new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, the Company has a total issued share capital of 71,738,224 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 71,738,224.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

  About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK, and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.460 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices) and an online retail business ("Animed Direct").

 

The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQKBBQNBKDNCK
Date   Source Headline
19th Feb 20104:20 pmRNSInterim Results
19th Feb 20104:20 pmRNSProposed placing and Acquisition
10th Dec 20097:00 amRNSAnnual General Meeting Statement
7th Dec 200910:07 amRNSHolding(s) in Company
7th Dec 20097:00 amRNSAppointment of Nominated Advisor and Broker
1st Dec 20097:00 amRNSAcquisition
18th Nov 20095:19 pmRNSPosting of Annual Report
11th Nov 200910:58 amRNSChange of Registered Office
3rd Nov 20097:00 amRNSHolding(s) in Company
3rd Nov 20097:00 amRNSHolding(s) in Company
20th Oct 200910:35 amRNSHolding(s) in Company
20th Oct 200910:07 amRNSHolding(s) in Company
19th Oct 200910:19 amRNSHolding(s) in Company
16th Oct 200911:52 amRNSDirector/PDMR Shareholding
25th Sep 20095:08 pmRNSDirector/PDMR Shareholding
24th Sep 20094:03 pmRNSHolding(s) in Company
22nd Sep 20097:00 amRNSPreliminary Results
15th Sep 200911:26 amRNSHolding(s) in Company
3rd Sep 200912:03 pmRNSHolding(s) in Company
28th Aug 20098:18 amRNSHolding(s) in Company
27th Aug 20094:53 pmRNSHolding(s) in Company
27th Aug 200912:08 pmRNSHolding(s) in Company
27th Aug 20098:57 amRNSHolding(s) in Company
26th Aug 20094:08 pmRNSHolding(s) in Company
26th Aug 20092:47 pmRNSHolding(s) in Company
7th Aug 20096:24 pmRNSHolding(s) in Company
17th Jul 20097:00 amRNSAcquisition
14th Jul 20097:00 amRNSTrading Update
13th Jul 20097:00 amRNSLTIP Award
30th Apr 20094:10 pmRNSHolding(s) in Company
21st Apr 20097:00 amRNSAcquisition
14th Apr 200910:48 amRNSHolding(s) in Company
7th Apr 20095:22 pmRNSHolding(s) in Company
2nd Apr 20094:08 pmRNSHolding(s) in Company
25th Mar 20099:50 amRNSHolding(s) in Company
24th Mar 20098:00 amRNSDirector/PDMR Shareholding
17th Mar 20097:00 amRNSInterim Results
3rd Mar 20097:00 amRNSAcquisition
27th Feb 20098:30 amRNSNotice of Results
6th Feb 20093:25 pmRNSHolding(s) in Company
29th Jan 20094:32 pmRNSHolding(s) in Company
20th Jan 20093:47 pmRNSHolding(s) in Company
20th Jan 20097:00 amRNSAcquisition
13th Jan 20097:00 amRNSBoard Change
8th Dec 20087:00 amRNSDirector Dealings
4th Dec 20083:15 pmRNSAGM Result
4th Dec 20087:00 amRNSAnnual General Meeting Statement
2nd Dec 20087:00 amRNSAcquisition of Joel Veterinary Clinic Ltd
2nd Dec 20087:00 amRNSAcquisition of Harbour Veterinary Group
28th Nov 20082:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.